Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Pharma Q4 Results Preview: Bristol, Allergan, Gilead, GSK, Sanofi, Teva

Feb 02 2018

• By Scrip Team

SC1802_2017-18 Signs_681245989_1200.jpg — Previewing biopharma's earnings calls

Related Content

Bristol's Strong SITC: IDO, 1L Kidney Cancer And New Mechanism Data Bode Well

Nov 14 2017

PD-1 Earnings Roundup: Buckle Up For A Bumpy Ride

Nov 15 2017

Teva CEO Schultz Walks Smack Into A Rough Financial Situation

Nov 02 2017

GSK Bags Barron As R&D Boss As Vallance Joins UK Government

Nov 08 2017

Gilead Completes HCV Clinical Development With Vosevi Approval

Jul 18 2017

Gilead Raises HCV Guidance Slightly, Still Mum On M&A

Jul 26 2017

Allergan Hopes To Add Bipolar Depression To Vraylar's Label

Dec 18 2017

Schultz Swings The Cleaver At Teva, Cutting 25% Of The Workforce

Dec 14 2017

Allergan Relying On 'Six Stars' And Other R&D Programs To Blunt Restasis Blow

Jan 19 2018

Namenda XR Generics Coming Soon? US Court Rulings Clear Path For Multiple Launches

Jan 30 2018

J.P. Morgan Notebook Day 1: Tax Reform At Last, Allergan's Job Cuts, Teva Turnaround, Biogen's Cash, And Getting FDA-Friendly

Jan 09 2018

Complex Generics: US FDA Still Wants Comparative Clinical Endpoint Studies For Inhaled, Nasal Drugs

Jan 16 2018

Pfizer Mum On Consumer Business Plans As Analysts Say Spin-off

Feb 01 2018

Walmsley Takes On Oncology: Can GSK Become A Power Player?

Jan 16 2018

J.P. Morgan Notebook Day 2: Walmsley On Diversity, Amgen's Overseas Cash, Growing Opdivo, Mylan On US Generic Pricing, Boston's Pipeline And J&J In Alzheimer's

Jan 10 2018

AbbVie Expects 9% Tax Rate, Thanks To US Tax Reform Law

Jan 26 2018

Ablynx, Bioverativ Buys Drive Sanofi's Hematology Reign

Jan 29 2018

Sanofi Builds Blood Disorder Specialty With Bioverativ Buy

Jan 22 2018

Gilead Says 16 Cancer Centers Getting Ready To Administer Yescarta

Oct 27 2017

Bristol's Opdivo Delivers, But CheckMate 227 Uncertainties Cloud Quarter

Oct 27 2017

Gilead Offers Split Guidance For HCV; Expects Further Decline In 2017

Feb 08 2017

Teva Catches A Break On Copaxone 40mg, But For How Long?

Feb 28 2017

Related Companies

Bristol Myers Squibb Company

Eli Lilly and Company

Allergan plc

Kite Pharma, Inc.

Gilead Sciences, Inc.

AbbVie Inc.

GSK plc

Genentech, Inc.

Roche Holding AG

ViiV Healthcare

Novartis AG

Viatris Inc.

Hikma Pharmaceuticals plc

Sanofi

Sanofi

Ablynx N.V.

Boehringer Ingelheim GmbH

Merck KGaA

Novartis AG

Biogen, Inc.

BioMarin Pharmaceutical Inc.

Teva Pharmaceutical Industries Ltd.

Momenta Pharmaceuticals, Inc.

Additional Topics

Sales & Earnings Business Strategies Companies Clinical Trials Commercial BioPharmaceutical

More from Earnings

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window